Concepedia

Martin Potts

MP

9

Publications

2.7K

Citations

9

H-Index

2017

Active since

Affiliations

University of Cambridge(Current)

Cambridge University Hospitals NHS Foundation Trust

Wellcome/MRC Cambridge Stem Cell Institute

Medical Research Council

Cardiff University

Martin Potts is an author at University of Cambridge specializing in gene expression, natural sciences, and chromatin.

ORCID

Top concepts

Publications per year

2017–2024

9

Publications

9

SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion

Petra Mlčochová, Steven A. Kemp, Mahesh Shanker Dhar et al. · Nature · 2021 · 1.4K citations · Full text

Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity

Bo Meng, Adam Abdullahi, Isabella A.T.M. Ferreira et al. · Nature · 2022 · 1.1K citations · Full text

Nuclear phosphorylated Dicer processes double-stranded RNA in response to DNA damage

Kaspar Burger, Margarita Schlackow, Martin Potts et al. · The Journal of Cell Biology · 2017 · 103 citations · Full text

, , +17

Human cytomegalovirus protein RL1 degrades the antiviral factor SLFN11 via recruitment of the CRL4 E3 ubiquitin ligase complex

Katie Nightingale, Martin Potts, Leah M. Hunter et al. · Proceedings of the National Academy of Sciences · 2022 · 34 citations · Full text

Atypical B cells and impaired SARS-CoV-2 neutralization following heterologous vaccination in the elderly

Isabella A.T.M. Ferreira, Colin Y.C. Lee, William S. Foster et al. · Cell Reports · 2023 · 24 citations · Full text

Rows per page

1–5 of 9